Skip to content

Effect of Glycerol-Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest

Effect of Glycerol-Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06185595
Enrollment
37
Registered
2023-12-29
Start date
2024-01-08
Completion date
2024-06-28
Last updated
2025-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydration

Keywords

hydration, euhydration, fluid balance, fluid retention

Brief summary

The objective of this study is to determine the effect of consumption of drinks with varying amounts of glycerol and electrolytes on fluid balance at rest.

Interventions

OTHERBeverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.

9.3 oz (273 ml) aliquot of one of the study beverages every 15 min for a total of 28 oz (828 ml) over a 45-min period, followed by 15 min of rest. Flavored water matched for sweetness, color. flavor, but cannot be matched for saltiness. All sodium-containing drinks will include a base blend of other electrolytes (potassium 15 mmol/L, magnesium 8 mmol/L, and calcium 5 mmol/L).

Sponsors

PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is male or female * If female, subject is not pregnant * Subject is 18-50 years of age, inclusive * You are at least recreationally active (engaged in light to moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 30 min at a time) * Subject does not smoke (or has quit for at least 6 months) * Subject is not taking medication that may interfere with the study (e.g., diuretics) * Subject has no health conditions that would interfere with the study as indicated on the general health questionnaire (GHQ), e.g. cardiovascular, renal, or metabolic diseases * Subject is willing to avoid alcohol consumption 24 hours prior to visit(s) * Subject is willing to fast overnight (\ 8-12 hours) * Subject is willing to refrain from vigorous exercise for 24 hours * Subject is willing to eat the exact same food the day prior to each visit to the laboratory * Able to speak, write, and read English * Provision of written consent to participate

Exclusion criteria

* Subject has participated in a clinical trial within the past 30 days * Subject has participated in any PepsiCo trial within past 6 months * Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk * Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Fluid balanceChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90,120 and 180 minutesChange in body mass to the nearest 0.005 kilogram (kg) using a platform scale

Secondary

MeasureTime frameDescription
Urine massChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutesBy urine mass scale in grams (g)
Urine specific gravityChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90,120 and 180 minutesBy USG digital pen refractometer
Blood sodiumChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutesBy iSTAT Blood Electrolyte and Chemistry Analyzer (CG8+ cartridge) in mmol/L
Blood glucoseScreening visit onlyGlucometer for point of care test in mg/dL
Percent change in plasma volumeChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutesCalculated from hematocrit and hemoglobin concentration
Fluid retentionChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90,120 and 180 minutesAs a percent (%)
Blood pressureChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutesmmHg by automatic sphygmomanometer
Heart rateChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutesBeats per minute (bpm) by heart rate monitor
Subjective measures of gastrointestinal discomfort and headacheChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutesVisual Analog Scale (VAS) symptom rating of how you feel right now by placing a slash along a 100 millimeter (mm) vertical line anchored from 0 mm (None) to 100 mm (Severe). Fewer symptoms and lower numbers are better.
Menstrual cycle phaseFemale participants log menstrual flow throughout study participation. The three study sessions (2-45 days apart) are scheduled to avoid menses and can be completed in the same menstrual cycle, or in 3 different cycles (3 different months) if needed.Date of last menstrual period by self-report of female participant
Serum glycerol concentrationChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutesBy Sigma Aldrich glycerol assay kit in mmol/L

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026